https://www.mdanderson.org/newsroom/archived-news/md-anderson-cancer-c.h00-159069501.html
ARCHIVED: MD Anderson & Adaptimmune partner to advance development of immunotherapies targeting...
Adaptimmune Therapeutics and The University of Texas MD Anderson Cancer Center announced today they have entered into a multi-year strategic alliance designed...
md andersonarchivedadaptimmunepartner
https://www.fiercebiotech.com/biotech/astellas-teams-adaptimmune-to-create-car-ts-tcr-therapies
Astellas teams with Adaptimmune to create CAR-T, TCR therapies | Fierce Biotech
Jan 14, 2020 - Astellas has teamed up with Adaptimmune to develop allogeneic chimeric antigen receptor T-cell (CAR-T) and T-cell receptor (TCR) therapies.
to create
https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-adaptimmune-therapeutics-mei-pharma-dynavax-technologies-aim-immunotech-or-meridian-bioscience-301067718.html
Thinking about buying stock in Adaptimmune Therapeutics, MEI Pharma, Dynavax Technologies, AIM...
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ADAP, MEIP, DVAX, AIM, and VIVO. To see how InvestorsObserver's proprietary scoring...
thinking about buying
https://www.fool.com/earnings/call-transcripts/2021/08/09/adaptimmune-therapeutics-plc-adap-q2-2021-earnings/
Adaptimmune Therapeutics plc (ADAP) Q2 2021 Earnings Call Transcript | The Motley Fool
Aug 9, 2021 - ADAP earnings call for the period ending June 30, 2021.
earnings call transcript
https://www.benzinga.com/insights/analyst-ratings/24/11/42222004/demystifying-adaptimmune-therapeutics-insights-from-4-analyst-reviews
Demystifying Adaptimmune Therapeutics: Insights From 4 Analyst Reviews - Benzinga
therapeutics insightsdemystifyingadaptimmuneanalystreviews
https://www.adaptimmune.com/
Adaptimmune (ADAPY)
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
adaptimmune
https://www.gov.uk/employment-tribunal-decisions/p-singadia-v-adaptimmune-ltd-3314941-slash-2023
P Singadia v Adaptimmune Ltd: 3314941/2023 - GOV.UK
Employment Tribunal decision.
pvltduk